Personalized medicine is a medical model that uses medical decisions, practices, interventions and/or products that are tailored to the individual patient based on their predicted response or risk of disease.

RSK Medical Inc. brings a wealth of experience, knowledge, progressive learning and keen responsiveness as a medical device supplier and is dedicated to providing innovative and disruptive medical device technologies to the Canadian clinical community. These provide clinicians and hospitals with improved outcomes, preventative and therapeutic long-term care for their patients.

Based on strong clinical data and engineering, our products create and deliver substantial economic value to the health care system.

Latest News

“Pocket Press” for Cardiac Implantable Electronic Devices

August 10, 2023

RSK Medical has begun distribution of the “Pocket Press” for Cardiac Implantable Electronic Devices (CIED*) across Canada. This new modern pressure bandage is manufactured by Compress Innovations after significant experience in the wound and implantable cardiac rhythm devices industry. With significant CRM experience in the industry, we look forward to standardizing and improving the pressure dressing over devices to reduce the incidence of hematomas in this large group of patients.

The Pocket Press is pre-assembled with a standardized level of compression utilizing a 3-anchor design and a high density foam to maximize compression over the pocket. Please view the Virtual Inservice video at the website: We are pleased to provide a means of reducing the number of hematomas and therefore the further risk of infections in device patients.

TricValve® – Transcatheter Bicaval Valves System

April 13, 2023

We are very pleased to announce a distribution agreement across Canada for the P&F TRICVALVE TRANSCATHETER BICAVAL VALVES system. It is designed for the treatment of severe and symptomatic Tricuspid Regurgitation. The system consists of two self-expanding valves for the treatment of patients with hemodynamically relevant tricuspid insufficiency and caval reflux. The bioprostheses are implanted percutaneously into the inferior and superior vena cava without disturbing the native tricuspid valve. It is especially intended for use for patients who are not candidates for open surgical therapy.

The system does not yet have regulatory approval in Canada. The TRICVALVE system is approved for use in Europe (CE Mark) with now over 1,000 implants worldwide.

Pulmonary Valve Replacement-VENUS-MEDTECH agreement

November 7th, 2022

RSK Medical Inc. is pleased to announce a distribution agreement with VENUS-MEDTECH, a leader in transcatheter structural heart valve therapies in Asia and Europe.  RSK Medical is distributing the VENUS-P Valve system which is the first self-expanding nitinol stent designed specifically for pulmonary valve replacement.
The purpose of the VENUS-P is to replace the native or repaired  pulmonary heart valve with an artificial (biological) valve using a minimally invasive approach to treat RVOT dysfunction to restore proper pulmonary valve function.
To date, VENUS-P Valve implants have been completed at St. Paul’s Hospital, Toronto General Hospital and the Montreal Heart Institute under the special access process via Health Canada.

Our People

Scott Kadwell

Scott Kadwell is the PRESIDENT of RSK Medical Inc. With over 40+ years in the cardiovascular medical device business in Canada, he has held senior national business and marketing management positions with many of the largest global medical device companies such as SulzerMedica, Guidant, BSC, Medtronic and Sorin Group while residing in Calgary, Vancouver and Toronto.

The cardiovascular specialities related to his experience have been in the fields of interventional cardiology and radiology, electrophysiology, cardiac surgery and vascular/ endovascular therapies.

Scott was formerly an active member at MEDEC Association participating in a number of committees to develop policies, therapy awareness and financial reimbursement for new device technologies.

Greg Whitwham

Greg Whitwham is the “DIRECTOR of Sales” in a full-time consultant role to RSK Medical Inc. Greg is responsible for sales nationwide across the interventional cardiology, radiology and vascular/cardiac surgery product areas.

Greg joined the RSK Medical team with significant medical device industry experience working for companies like Getinge as a Territory Manager, Olympus Corporation as Marketing Manager and Product Manager and Stryker as a Product Manager.

His educational background comes from the University of Western Ontario (London) including both a Bachelor of Engineering Science (Mechanical) and a Bachelor of Science (Medical Biophysics).

Dr. Frederick Kozak

Dr. Frederick Kozak is a Pediatric Otolaryngologist at BC Children’s Hospital and Clinical Professor in the Department of Surgery at the University of British Columbia. In his career of over twenty years, Dr. Kozak has been extensively involved as a clinician, researcher, medical educator and administrator.

His main clinical area of interest is hearing loss in the pediatric population and he is the Surgical/Medical Director of the Pediatric Cochlear Implant Program in B.C. He has published over 40 peer reviewed publications and he has presented his research and educational expertise locally, nationally and internationally. His extensive involvement in administrative committees includes being Vice-Chair and Chair of the Medical Advisory Committee for Children’s and Women’s Hospital of BC from 2002-2007.

Dr. Kozak has provided consultation to several pharmaceutical and device manufacturers over the past 20 years.

Gordon Collins

Gordon Collins is a Business Advisor, Executive Coach and Facilitator. Gordon is the president and founder of The Coaching Network based in Oakville, Ontario. He is also an associate with SGA – a consulting firm specializing in developing ‘C-Suite’ influencing capabilities globally and an adjunct faculty member of the Telfer Centre for Executive Leadership – University of Ottawa.

Gordon specializes in developing Business Effectiveness – through building leadership capability, creating team alignment and designing innovative approaches to creating competitive advantage. He has in-depth experience in the Private, Public and Non Profit sectors as well as a global practice across North and South America, Europe, Middle East, Asia Pacific and Africa.

Gordon has provided consultation to a large number of medical device, biotech and pharmaceutical companies across North America and Europe over the past 20 years.

PO Box 30040 RPO Boxgrove
90 Copper Creek Dr.
Markham, Ontario
L6B 0R5 Canada